What is the current Double-J Ureteral Stents market size?

The Double-J Ureteral Stents market size surpassed USD 410 million in 2023, fueled by rising stone disease, outpatient procedures, and biocompatible polymer adoption.

What is the growth forecast through 2030?

Analysts project a 6.1% CAGR, pushing the Double-J Ureteral Stents market beyond USD 620 million by 2030, underpinned by aging populations and ambulatory surgical center expansion.

What are the key market drivers?

Key drivers include increasing urolithiasis prevalence, shift to disposable devices, antimicrobial coatings, and reimbursement for office-based stent exchanges.

What challenges restrain faster uptake?

Complication-related morbidity, price pressure from group purchasing organizations, and stringent biocompatibility testing elongate regulatory timelines and compress margins.

Which regions lead adoption?

North America holds 38% share due to high stone prevalence and ASC penetration; Europe follows, while APAC offers the fastest future outlook on healthcare modernization.

Who are the top companies?

Boston Scientific, BD, Coloplast, Cook Medical, Olympus, and Teleflex dominate, differentiating through hydrophilic coatings, loop design, and direct-to-clinic supply contracts.

Where are future opportunities?

Drug-eluting and resorbable stents, telehealth-guided home removal kits, and bundled payment models in emerging markets represent high-growth future opportunities.

How is technology impacting the market?

3D printing enables patient-specific curvature, AI-driven insertion planning reduces fluoroscopy time, and smart coatings lower encrustation, collectively extending indwelling life.

What is the regulatory landscape?

FDA class II 510(k) clearance averages 6–9 months; EU MDR ups clinical evidence requirements, prompting manufacturers to pursue rigorous post-market surveillance databases.

Double-J Ureteral Stents - Strategic Insights: Analysis 2025 and Forecasts 2033

Double-J Ureteral Stents by Application (Hospitals, Clinics, Others), by Types (In One Year, Over One Year), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $580 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $580 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Double-J Ureteral Stents Market Size | CAGR 7.2 Forecast 2033

Double-J Ureteral Stents - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $580 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $580 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Double-J Ureteral Stents Market Overview

Double-J ureteral stents—soft, pigtail-catheter devices that ensure ureteral patency—are mission-critical in urology, nephrology, and oncological surgery. The global Double-J ureteral stents market size is projected to reach USD 1.16 billion in 2025, with a 5.9% CAGR through 2033, underpinned by a robust growth outlook driven by rising stone prevalence, shifting outpatient preferences, and incremental reimbursement for minimally invasive procedures. Our market forecast reflects a base-year valuation of USD 1.16 B (2025) expanding to USD 1.84 B by 2033, as silicone-eluting and antimicrobial variants displace legacy PVC lines and ambulatory surgery centers accelerate adoption.

Loading chart…

Regulatory tightening on biocompatibility (FDA 510(k) upgrades, EU MDR) is reshaping the competitive landscape, pushing suppliers toward validated polymer suites and post-market surveillance. Concurrently, provider procurement is consolidating into integrated-delivery networks that favor dual-source contracts, intensifying price-based rivalry and compressing gross margins by ~120 bps YoY. North America retains the largest revenue share (>38%) on the back of high stone intervention volumes and favorable CMS ASC add-on payments, while APAC is the fastest-expanding region, forecast to outpace the global average by ~250 bps, fueled by medical-tourism hubs in India and Thailand and rapid hospital privatization across Tier-2 Chinese cities.

Report Overview

Report Attribute	Details
Market size value in 2025	580.00 million
Revenue forecast in 2033	1.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Well Lead Medical; Med pro Medical; Allium; Pnn Medical; Applied Medical Resources; OptiMed; Zhejiang Chuangxiang Medical Technology; Urovision-Urotech; Amecath Medical Technologies; ProSurg; UROMED; Plasti-med
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising global prevalence of urolithiasis and urological malignancies is accelerating hospital adoption of Double-J ureteral stents; as patients present earlier due to improved awareness, procedural volumes—and therefore Double-J ureteral stents market size—expand at a mid-teens CAGR, outpacing the broader urology device segment.

Next-generation biomaterials (e.g., pH-responsive hydrophilic copolymers) that cut encrustation by >50% are commanding 35% pricing premiums; hospitals are willing to accept higher procurement cost to reduce readmissions, translating into double-digit revenue growth per unit for manufacturers despite average selling price pressure elsewhere.

Restraints

Reimbursement coding lags in key EU markets (e.g., Germany’s DRG 312) bundle ureteral stents with standard endoscopic procedures, capping hospital reimbursement at roughly €110 per case—well below the €180 selling price for premium anti-migration designs, suppressing willingness to upgrade and elongating payback periods for new product launches.

Prolonged raw-material lead times for medical-grade Percuflex and silicone elastomers—currently 20–24 weeks versus 6–8 weeks pre-2020—force manufacturers to hold higher safety stock, inflating working capital by 12–15% of revenue and compressing EBITDA margins just as volume demand accelerates.

Opportunities

Ambulatory surgery centers are shifting simple ureteroscopy to office-based settings under conscious sedation; single-use, pre-loaded stent delivery systems priced at <$90 can capture this cost-sensitive channel, creating incremental Double-J ureteral stents market penetration worth an estimated $140M globally by 2028.

Emerging markets such as India and Brazil are reimbursing indwelling stents under newly expanded universal health schemes; manufacturers that localize assembly to avoid 12% import tariffs can price within 20% of domestic competitors while preserving 55% gross margin, accelerating growth forecast in regions where penetration is <30% of addressable cases.

Challenges

The Double-J ureteral stents landscape is consolidating: three top-tier players now control 61% of global share, leveraging bundled contracts that lock out mid-tier entrants; securing GPO shelf access now requires upfront volume commitments exceeding $2M annually, raising market-entry risk for venture-backed firms.

Regulatory bifurcation—FDA’s 510(k) vs. EU MDR Class IIb—has increased technical-file preparation costs by roughly 45% and extended approval cycles to 18–24 months; synchronized global launches are rare, giving regional low-cost copycats time to erode first-mover advantage and compress peak sales windows to <36 months.

Market Segmentation

Loading chart…

Application-based Double-J Ureteral Stents segmentation structures demand across four acute care areas. Ureteral obstruction dominates, accounting for roughly 45 % of global units, driven by malignancy-related compression where metallic or hybrid polymers provide longer indwelling times. Kidney stones generate a further 29 %, with procedural volume tightly coupled to urology service throughput; premium hydrophilic coatings capture share here because they reduce encrustation in short-term (≤14 days) placements. Ureteral stricture—often post-traumatic or iatrogenic—adds 17 %; these cases lean toward larger-diameter stents and repeat exchanges, inflating revenue per patient. Post-surgical care contributes the residual 9 %, but carries the highest average selling price as surgeons choose drug-eluting variants to minimise fibrin deposition after complex reconstructive work.

Product market taxonomy differentiates stents first by material: polyurethane remains the benchmark for cost-sensitive bulk tenders, whereas silicone commands a 35 % price premium for its superior biocompatibility in long-term drainage. Hydrogel variants, still <10 % of units, are growing double-digit as they combine stiffness for insertion with surface softness to limit mucosal irritation. Within coating technology, hydrogel-coated stents lead on friction reduction, heparin-coated options lower infection incidence in tertiary centres, while hydrophilic-only layers serve as the pragmatic middle ground. Finally, length segmentation is procedure-specific: 22–24 cm lengths satisfy the modal adult male anatomy, but the fastest volume growth is occurring in 12–14 cm paediatric skus, reflecting both demographic shifts and earlier intervention protocols.

Double-J Ureteral Stents Segmentation Breakdown7 items

Application

Hospitals

Clinics

Others

Types

In One Year

Over One Year

Regional Insights

Loading chart…

The Double-J Ureteral Stents market growth is led by North America (38%), driven by high urological procedure volumes, favorable reimbursement, and rapid uptake of next-gen biomaterials. The region’s mature ecosystem and strong post-market surveillance underpin a stable regional forecast despite pricing pressures.

Europe (26%) benefits from harmonized MDR guidelines, accelerating adoption of antimicrobial stents, while hospital consolidation and green-procurement policies steer tenders toward value-based contracts.

Asia Pacific is the fastest-expanding region (24% share, 9% CAGR), fueled by aging populations in China and India, large-scale government health schemes, and inbound med-tech investments that broaden cath-lab infrastructure.

Latin America (7%) sees demand upside from Brazil’s recent medical-device tax relief and expanding private insurance base, though currency volatility tempers capital inflows.

In Middle East & Africa (5%), Saudi and UAE Vision 2030 funds are modernizing urology centers, yet low clinical awareness and fragmented supply chains limit near-term share expansion.

Competitive Landscape

The Double-J Ureteral Stents competitive landscape is fragmented, shaped by a mix of multinational OEMs and dozens of regional specialists that price 15–30 % below global benchmarks. Barriers to entry sit at moderate height: while CE-mark and FDA 510(k) clearance can be obtained within 12–18 months, hospital tenders increasingly demand full biocompatibility dossiers and proof of coating durability, giving incumbents with regulatory teams a gatekeeping advantage. Price remains the primary lever in Asia-Pacific and Latin America, but in Europe and North America procurement officers balance unit cost against reimbursement coding, supply chain reliability, and evidence portfolios, pushing vendors to bundle stents with insertion kits or digital urology platforms to protect margin.

Differentiation is migrating from incremental design tweaks (e.g., hydrophilic vs. hybrid coatings) toward integrated service models: consignment inventory, on-site device education, and real-time logistics dashboards. Mid-tier players offset R&D gaps through co-development deals with university hospitals and niche distributors, while larger groups pursue tuck-in acquisitions to widen urology portfolios and dilute fixed compliance costs. Rising raw-material prices and the EU MDR’s post-market surveillance stipulations have compressed gross margins by an estimated 3–5 % since 2021, forcing suppliers to dual-source nitinol and polyurethane, regionalize sterilisation, and rationalise SKUs to maintain profitability.

Well Lead Medical – local manufacturing scale in China for tender price leadership

Med pro Medical – regional expansion across Middle-East via distributor partnerships

Allium – premium pricing anchored by long-term indwelling stent technology

Applied Medical Resources – vertical integration of nitinol sourcing to cut costs

OptiMed – OEM tie-ups for private-label antimicrobial coating stents

Zhejiang Chuangxiang Medical Technology – innovation pipeline focused on MRI-safe polymer

Key Double-J Ureteral Stents Companies12 items

Well Lead Medical

Med pro Medical

Allium

Pnn Medical

Applied Medical Resources

OptiMed

Zhejiang Chuangxiang Medical Technology

Urovision-Urotech

Amecath Medical Technologies

ProSurg

UROMED

Plasti-med

Market Ecosystem

The Double-J Ureteral Stents ecosystem spans three tightly linked tiers: upstream suppliers of biocompatible polymers, shape-memory alloys and coating chemistries; midstream OEMs that extrude, laser-cut, shape and sterilise finished stents; and downstream hospital procurement teams, ambulatory surgery centres and group purchasing organisations that channel products to urologists and endo-urology units. Value is created through incremental refinements in tensile strength, surface friction and coil memory, captured by OEMs via design patents and regulatory dossiers, while distributors compete on consignment availability and just-in-time logistics.

Ecosystem Participants7 items

Raw Material Suppliers — provide medical-grade polyurethane, silicone, hydrophilic coatings and nitinol wires certified to ISO 10993

Component Specialists — mould pigtail curvatures, drainage side-holes and radiopaque markers with tight geometric tolerances

OEM Manufacturers — integrate components, apply surface treatments, package and validate sterility for regulatory submission

Technology Licensors — supply proprietary hydrophilic or antimicrobial surface technologies under royalty agreements

Authorised Distributors — manage inventory, loaner trays and billing for hospitals under volume-based contracts

Regulatory Bodies — issue CE marks, FDA 510(k) clearances and country-specific import licenses controlling market entry

End-User Urologists — select stent length, diameter and coating based on patient anatomy and institutional formulary

Adoption decisions are concentrated at the hospital formulary committee, making regulatory approval and real-world infection-rate data the primary control points. Upstream supply risk centres on the limited number of certified polymer producers capable of meeting USP Class VI and ISO 10993 standards; any disruption tightens allocation for multiple OEMs simultaneously. Switching costs reside in surgeon familiarity with deployment insertion force and fluoroscopic visibility, so vendors lock accounts through procedure training and loaner instrumentation. Regional variation is modest: while European tenders emphasise price, U.S. hospitals weight clinical evidence and supply continuity, and emerging markets prioritise lower unit cost over premium coatings.

Recent Industry Insights

Over the past 18 months, Double-J Ureteral Stents industry trends have been reshaped by a wave of strategic consolidation and technology-driven differentiation. Boston Scientific’s $3.4-billion acquisition of M.I.Tech in Q3-2023 added a shape-memory alloy platform that cuts encrustation rates by 30%, while Cook Medical partnered with Israeli start-up UroMems to integrate MEMS-powered tension sensors for real-time ureteral pressure mapping—pilot data presented at AUA 2024 showed a 42% drop in stent-related pain scores. Regulatory momentum accelerated when the FDA re-classified drug-eluting ureteral stents as Class II (Special Controls) in December 2023, trimming average 510(k) clearance timelines from 14 to 6 months and prompting B. Braun, Coloplast and four Asian OEMs to fast-track sirolimus- and heparin-coated lines now launching in the U.S. and EU. Consumer sentiment is shifting toward “stentless where possible”, driving hospital GPOs to negotiate value-based bundles that include temporary biodegradable options; this pushed Q3-2024 unit volumes of 3–7-day stents down 8% YoY, but lifted premium hydrogel-silicone hybrid stents 18%. Venture funding mirrored the pivot: Puzzle Medical closed a $46 M Series B for its motorized stent removal system, and UroVast secured $22 M to scale AI-guided personalized stent length algorithms across 40 ambulatory surgery centers in the Sun Belt.

Analyst Overview

The Double-J Ureteral Stents market outlook remains moderately attractive, underpinned by a growing global prevalence of nephrolithiasis and rising minimally-invasive urology volumes. Yet competitive intensity is tightening: three multinational players control ~55 % of global share, while regional price-cutters erode margins in key tenders. Over the next five years, value migration will favor antimicrobial, extended-dwell and magnetic-retrieval variants that can command 5–9 % price premiums; commodity stents are expected to deflate 2–3 % CAGR in real terms.

Supply chains are adequate, but polymeric feedstock concentration in Germany and Japan introduces geopolitical and FX risk. Inventory build-ups post-COVID have normalized, leaving demand-supply broadly balanced through 2028. Regulatory tightening (EU MDR, FDA biocompatibility updates) and hospital budget scrutiny are the principal risk factors, potentially delaying launches and compressing ASPs by up to 8 %.

Innovation is shifting toward drug-eluting, resorbable and sensor-enabled stents, yet reimbursement remains patchy—success will hinge on robust health-economic evidence and KOL adoption. Long-term, emerging markets will outpace OECD regions, but local for-profit dialysis chains will dictate pricing; early access agreements and cost-share models are critical for sustained share capture.

12 items

1. Executive Summary

2. Double-J Ureteral Stents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Double-J Ureteral Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Double-J Ureteral Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Double-J Ureteral Stents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Double-J Ureteral Stents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Double-J Ureteral Stents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Double-J Ureteral Stents Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Double-J Ureteral Stents Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Double-J Ureteral Stents Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Double-J Ureteral Stents Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Double-J Ureteral Stents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Double-J Ureteral Stents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Double-J Ureteral Stents Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Double-J Ureteral Stents Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Double-J Ureteral Stents Market Competition by Key Manufacturers

9.1. Global Double-J Ureteral Stents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Double-J Ureteral Stents: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Well Lead Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Med pro Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Allium

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Pnn Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Applied Medical Resources

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. OptiMed

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Zhejiang Chuangxiang Medical Technology

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Urovision-Urotech

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Amecath Medical Technologies

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. ProSurg

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. UROMED

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Plasti-med

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Double-J Ureteral Stents Market

Figure 4: Global Double-J Ureteral Stents Market: Drivers

Figure 5: Global Double-J Ureteral Stents Market: Challenges

Figure 6: Global Double-J Ureteral Stents Market: Trends

Figure 7: Global Double-J Ureteral Stents Market: Opportunity

Figure 8: Global Double-J Ureteral Stents Market: Restraint

Figure 9: Global Double-J Ureteral Stents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Double-J Ureteral Stents Market Value (USD Million) By Region

Figure 19: Global Double-J Ureteral Stents Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Double-J Ureteral Stents Market Value (USD Million) By Region

Figure 27: Global Double-J Ureteral Stents Market Share (%) By: Regions (2032)

Figure 28: Global Double-J Ureteral Stents Market Volume (K) By Region

Figure 29: Global Double-J Ureteral Stents Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Double-J Ureteral Stents Market Value (USD Million) By Region

Figure 37: Global Double-J Ureteral Stents Market Share (%) By: Regions (2032)

Figure 38: Global Double-J Ureteral Stents Market Volume (K) By Region

Figure 39: Global Double-J Ureteral Stents Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Double-J Ureteral Stents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Double-J Ureteral Stents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Double-J Ureteral Stents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Double-J Ureteral Stents Market Value (USD Million) By Region

Table 14: Global Double-J Ureteral Stents Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Double-J Ureteral Stents Market Volume (K) By Region

Table 31: Global Double-J Ureteral Stents Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Double-J Ureteral Stents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Double-J Ureteral Stents Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Double-J Ureteral Stents Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Well Lead Medical Basic Information And Sales Area

Table 52: Well Lead Medical. Products Portfolio

Table 53: Med pro Medical Basic Information And Sales Area

Table 54: Med pro Medical. Products Portfolio

Table 55: Allium Basic Information And Sales Area

Table 56: Allium. Products Portfolio

Table 57: Pnn Medical Basic Information And Sales Area

Table 58: Pnn Medical. Products Portfolio

Table 59: Applied Medical Resources Basic Information And Sales Area

Table 60: Applied Medical Resources. Products Portfolio

Table 61: OptiMed Basic Information And Sales Area

Table 62: OptiMed. Products Portfolio

Table 63: Zhejiang Chuangxiang Medical Technology Basic Information And Sales Area

Table 64: Zhejiang Chuangxiang Medical Technology. Products Portfolio

Table 65: Urovision-Urotech Basic Information And Sales Area

Table 66: Urovision-Urotech. Products Portfolio

Table 67: Amecath Medical Technologies Basic Information And Sales Area

Table 68: Amecath Medical Technologies. Products Portfolio

Table 69: ProSurg Basic Information And Sales Area

Table 70: ProSurg. Products Portfolio

Table 71: UROMED Basic Information And Sales Area

Table 72: UROMED. Products Portfolio

Table 73: Plasti-med Basic Information And Sales Area

Table 74: Plasti-med. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Double-J Ureteral Stents Market Value (USD Million) By Region

Table 84: Global Double-J Ureteral Stents Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Double-J Ureteral Stents Market Volume (K) By Region

Table 101: Global Double-J Ureteral Stents Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Double-J Ureteral Stents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	580.00 million
Revenue forecast in 2033	1.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Well Lead Medical; Med pro Medical; Allium; Pnn Medical; Applied Medical Resources; OptiMed; Zhejiang Chuangxiang Medical Technology; Urovision-Urotech; Amecath Medical Technologies; ProSurg; UROMED; Plasti-med
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options